The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The development of COX2 inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Arzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationThe Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Drugs Which Inhibit Prostaglandin Biosynthesis
Flower, R. J. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06634-7 · Cited by 1,323
Self-citationSelective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,265
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 969
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 826
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35698-9 · Cited by 811
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Self-citationExpression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., & Hla, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117060 · Cited by 655
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118717 · Cited by 571
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
Characterization of inducible cyclooxygenase in rat brain
Breder, C. D., Dewitt, D., & Kraig, R. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550208 · Cited by 533
Arachidonic Acid Oxygenation by COX-1 and COX-2
Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., & Lanzo, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22903 · Cited by 523
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Fletcher, B. S., Kujubu, D. A., Perrin, D. M., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42840-2 · Cited by 491
Effects of Anti-inflammatory Drugs on Prostaglandin Biosynthesis
FLOWER, R., GRYGLEWSKI, R., HERBACZŃSKA-CEDRO, K., & VANE, J. R. (1972) · Nature New Biology · doi:10.1038/newbio238104a0 · Cited by 475
Self-citationKargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., & O'Neill, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690211 · Cited by 462
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
Masferrer, J. L., Seibert, K., Zweifel, B., & Needleman, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3917 · Cited by 461
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
Pasinetti, G. M., & Aisen, P. S. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00218-8 · Cited by 457
Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their Expression
Feng, L., Sun, W. Q., Xia, Y. Y., Tang, W. W., Chanmugam, P., Soyoola, E., Wilson, C. B., & Hwang, D. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1601 · Cited by 452
Merlie, J. P., Fagan, D., Mudd, J., & Needleman, P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68959-8 · Cited by 429
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., & Seibert, K. (1995) · Biochemical Journal · doi:10.1042/bj3050479 · Cited by 412
Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.
Kujubu, D. A., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42398-8 · Cited by 402
Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.
Masferrer, J. L., Zweifel, B. S., Seibert, K., & Needleman, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114850 · Cited by 402
Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.
Raz, A., Wyche, A., Siegel, N., & Needleman, P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69170-7 · Cited by 398
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., & Vane, J. R. (1980) · Nature · doi:10.1038/284271a0 · Cited by 392
Characterization of the human gene (PTGS2) encoding prostaglandin‐endoperoxide synthase 2
KOSAKA, T., MIYATA, A., IHARA, H., HARA, S., SUGIMOTO, T., TAKEDA, O., TAKAHASHI, E., & TANABE, T. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18804.x · Cited by 383
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. ‐., Ford‐Hutchinson, A. W., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701076 · Cited by 322
Kalgutkar, A. S., Marnett, A. B., Crews, B. C., Remmel, R. P., & Marnett, L. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000004e · Cited by 316
Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310
Sirois, J., & Richards, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42706-8 · Cited by 306
Pierce, J. W., Read, M. A., Ding, H., Luscinskas, F. W., & Collins, T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3961 · Cited by 302
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-Garcia, L., Chen, X.-M., Matijevic-Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
Willoughby, D. A., Moore, A. R., & Colville-Nash, P. R. (2000) · The Lancet · doi:10.1016/s0140-6736(99)12031-2 · Cited by 298
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Stimulation and Blockade of Prostaglandin Biosynthesis
Smith, W. L., & Lands, W. E. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34171-7 · Cited by 281
Prostaglandin Synthetase Inhibitors I
Shen, T. Y. (1979) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-66891-3_12 · Cited by 274
Inhibition of prostaglandin synthesis in man
Hámberg, M. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90470-6 · Cited by 273
Li, S., Wang, Y., Matsumura, K., Ballou, L. R., Morham, S. G., & Blatteis, C. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01225-1 · Cited by 270
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Sirois, J., Simmons, D. L., & Richards, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49951-1 · Cited by 255
Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00839-i · Cited by 252
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., & Marnett, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.925 · Cited by 252
A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes
Frölich, J. C. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01017-6 · Cited by 243
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231
Zhang, Y., Shaffer, A., Portanova, J., Seibert, K., & Isakson, P. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37166-6 · Cited by 229
Raz, A., Wyche, A., & Needleman, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1657 · Cited by 227
PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs
DeWitt, D. L., Meade, E. A., & Smith, W. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90396-7 · Cited by 222
Brooks, P., Emery, P., Evans, J. F., Fenner, H., Hawkey, C. J., Patrono, C., Smolen, J., Breedveld, F., Day, R., Dougados, M., et al. (1999) · Rheumatology · doi:10.1093/rheumatology/38.8.779 · Cited by 222
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTION
DuBois, R. N., Giardiello, F. M., & Smalley, W. E. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70274-0 · Cited by 209
O'Sullivan, M. G., Chilton, F. H., Huggins, E. M., & McCall, C. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42073-x · Cited by 208
Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study
Chrubasik, S., Eisenberg, E., Balan, E., Weinberger, T., Luzzati, R., & Conradt, C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00442-3 · Cited by 208
Tomlinson, R. V., Ringold, H. J., Qureshi, M. C., & Forchielli, E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80174-8 · Cited by 205
Dirig, D. M., Isakson, P. C., & Yaksh, T. L. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37497-x · Cited by 205
Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E., & Guay, J. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-9-1088 · Cited by 186
Cronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6377 · Cited by 182
Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R., & Weissmann, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14540 · Cited by 181
Selective inhibition of cyclooxygenase 2
Klein, T., Nüsing, R. M., Pfeilschifter, J., & Ullrich, V. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90205-4 · Cited by 180
Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes
Geng, Y., Blanco, F. J., Cornelisson, M., & Lotz, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.796 · Cited by 168
Mechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms
Ouellet, M., & Percival, M. D. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2232 · Cited by 166
Nishikawa, K., Morrison, A. R., & Needleman, P. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108738 · Cited by 155
Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S., & Otomo, S. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb07103.x · Cited by 154
Simmons, D. L., Botting, R. M., Robertson, P. M., Madsen, M. L., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3275 · Cited by 149
Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.
Roth, G. J., & Siok, C. J. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34756-7 · Cited by 147
Cyclooxygenase-2–derived lipoxin A4 increases gastric resistance to aspirin-induced damage
Fiorucci, S., de Lima, O. M., Mencarelli, A., Palazzetti, B., Distrutti, E., McKnight, W., Dicay, M. S., Ma, L., Romano, M., Morelli, A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36558 · Cited by 137
Mitchell, J. A., Saunders, M., Barnes, P. J., Newton, R. C., & Belvisi, M. G. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.907 · Cited by 137
Evett, G. E., Xie, W., Chipman, J. G., Robertson, D. L., & Simmons, D. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1496 · Cited by 133
Kalgutkar, A. S. S., Kozak, K. R., Crews, B. C., Hochgesang, G. P., & Marnett, L. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980303s · Cited by 118
EFFECT OF ASPIRIN ON HUMAN SEMINAL PROSTAGLANDINS
Collier, J., & Flower, R. J. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90225-x · Cited by 110
Self-citationNovel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents
Li, J. J., Norton, M. B., Reinhard, E. J., Anderson, G. D., Gregory, S. A., Isakson, P. C., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Seibert, K., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950878e · Cited by 109
Nonsteroidal Anti-Inflammatory Drugs, Acetaminophen, Cyclooxygenase 2, and Fever
Simmons, D. L., Wagner, D., & Westover, K. D. (2000) · Clinical Infectious Diseases · doi:10.1086/317517 · Cited by 101
Activity of nimesulide on constitutive and inducible cyclooxygenases.
TAVARES, I. A., Bishai, P. M., & Bennett, A. B. (1995) · PubMed · Cited by 98
Ochi, T., Motoyama, Y., & Goto, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00051-0 · Cited by 96
Farivar, R. S., Chobanian, A. V., & Brecher, P. I. (1996) · Circulation Research · doi:10.1161/01.res.78.5.759 · Cited by 92
The Dynamics of Prostaglandin H Synthases
So, O., Scarafia, L. E., Mak, A. Y., Callan, O., & Swinney, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5801 · Cited by 91
Wong, W. Y. L., DeWitt, D. L., Smith, W. L., & Richards, J. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-11-1714 · Cited by 91
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
Schwartz, J. I., CHAN, C., Mukhopadhyay, S., MCBRIDE, K., JONES, T., Adcock, S., MORITZ, C., Hedges, J. R., Grasing, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89
Greig, G. M., Francis, D. A., Falgueyret, J., Ouellet, M., Percival, M. D., Roy, P. J., Bayly, C. I., Mancini, J. A., & O’Neill, G. P. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.829 · Cited by 87
(1992) · PubMed · Cited by 85
Farber, J. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1535-1545.1992 · Cited by 85
Prostaglandins and the Aspirin-Like Drugs
Vane, J. R. (1972) · Hospital Practice · doi:10.1080/21548331.1972.11706162 · Cited by 83
Willis, A. L., Davison, P. M., Ramwell, P. W., Brocklehurst, W. E., & Smith, B. (1972) · Springer eBooks · doi:10.1007/978-1-4684-2844-5_12 · Cited by 74
A pharmacological analysis of aspirin.
COLLIER, H. O. J. (1969) · PubMed · Cited by 73
Appleton, I., Tomlinson, A., Mitchell, J. A., & Willoughby, D. A. (1995) · The Journal of Pathology · doi:10.1002/path.1711760413 · Cited by 64
A Pharmacological Analysis of Aspirin
COLLIER, H. O. J. (1970) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60566-9 · Cited by 64
Huang, H. T., Li, J. J., Garland, D. J., Chamberlain, T. S., Reinhard, E. J., Manning, R. E., Seibert, K., Koboldt, C. M., Gregory, S. A., Anderson, G. D., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950664x · Cited by 60
Therapeutic Roles Of Selective Cox-2 Inhibitors
Vane, J. R., & Botting, R. M. (2001) · Medical Entomology and Zoology · Cited by 58
Selective Inhibitors of Cyclooxygenase-2: Are They Really Effective, Selective, and GI-safe?
Wallace, J. L., Reuter, B. K., McKnight, W., & Bak, A. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199800001-00006 · Cited by 58
Cronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0236 · Cited by 55
Therapeutic roles of selective COX-2 inhibitors
Graham, D. Y. (2002) · Gastroenterology · doi:10.1016/s0016-5085(02)80092-0 · Cited by 54
Nomenclature for COX-2 Inhibitors
Vane, J. R., & Warner, T. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02837-3 · Cited by 50
de Arriba, A. F., Cavalcanti, F., Miralles, A., Bayón, Y., Alonso, A., Merlos, M., García-Rafanell, J., & FORN, J. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23038-8 · Cited by 49
Bazan, N. G., & Flower, R. (2002) · Nature · doi:10.1038/420135a · Cited by 42
Self-citationInvolvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory pain
Ventura‐Martínez, R., Díaz‐Reval, I., Déciga‐Campos, M., Terrón, J. A., Ramírez, A. M. D., & López‐Muñoz, F. J. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778475 · Cited by 38
Vago, T., Bevilacqua, M. T., & Norbiato, G. (1995) · PubMed · Cited by 38
O’Neill, G. P., Kennedy, B. P., Mancini, J. A., Kargman, S., Ouellet, M., Yergey, J. A., Falgueyret, J., Cromlish, W. A., Payette, P., Chan, C.-C., et al. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7276-8_16 · Cited by 28
Systematic pharmacological approach to the characterization of NSAIDs
Lora, M., Denault, J., Leduc, R., & de Brum-Fernandes, A. J. (1998) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90052-7 · Cited by 20
Cited by
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Chromone: A Valid Scaffold in Medicinal Chemistry
Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E., & Borges, F. (2014) · Chemical Reviews · doi:10.1021/cr400265z · Cited by 760
Osteoarthritis — an untreatable disease?
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1693 · Cited by 585
Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2
Kim, S. F., Huri, D. A., & Snyder, S. H. (2005) · Science · doi:10.1126/science.1119407 · Cited by 489
Metadata
- Authors
- Flower, R. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-03
- Volume
- 2
- Issue
- 3
- Pages
- 179-191
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2151534353
- Cited by
- 459
- References
- 127
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.